Patent · US Expired

Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride

US8114901B2 · kind B2 · utility

2Cited by

17References

2Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Julie Kay Bush · Fishers, US
Margaret Mary Faul · Zionsville, US
Susan Marie Reutzel-Edens · Zionsville, US

Key dates

Filing date	Jul 8, 2003
Grant date	Feb 14, 2012
Priority date	—
Expiry date	Nov 2, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and for inhibiting tumor growth using said salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.